Leukaemia & lymphoma Flashcards
Choose the most appropriate answer from the list.
- 70
- 20
- 30
- 40
- 50
- 500
- 5000
- 80
- 100
- 1000
Number of B cells /μL required to diagnose CLL
5000
Choose the most appropriate answer from the list.
- 70
- 20
- 30
- 40
- 50
- 500
- 5000
- 80
- 100
- 1000
% of CLL patients older than 65 years at time of diagnosis
70
Choose the most appropriate answer from the list.
- 70
- 20
- 30
- 40
- 50
- 500
- 5000
- 80
- 100
- 1000
% of cases that present with no anaemia or thrombocytopenia, with three or more areas of lymphoid involvement (Rai Stages I and II, Binet Clinical Stage B)
50
Choose the most appropriate answer from the list.
- 70
- 20
- 30
- 40
- 50
- 500
- 5000
- 80
- 100
- 1000
% of CLL patients in which one or more cytogenetic abnormalities have been found
80
Choose the most appropriate answer from the list.
- 70
- 20
- 30
- 40
- 50
- 500
- 5000
- 80
- 100
- 1000
% of cases which have the most common abnormality: del 13q.14
50
Choose the most appropriate treatment option from the list.
- Allogenic blood transfusion
- Dosatinib
- Allogenic stem cell transplantation
- Fresh frozen plasma
- Autologous blood transfusion
- Golimumab
- Autologous stem cell transplantation
- Hydroxychloroquine
- Azathioprine
- IFN-α infusion
- Daunorubicin infusion
- Imatinib
- Donor granulocyte infusion
- Methotrexate
- Donor lymphocyte infusion
- None of the above
A 50 year old man presents with weight loss, fatigue and night sweats. He is diagnosed with chronic myeloid leukaemia and treatment is commenced. Several months later it becomes clear that he is resistant to the main class pharmaceutical agents that were used.
Allogenic stem cell transplantation
Choose the most appropriate treatment option from the list.
- Allogenic blood transfusion
- Dosatinib
- Allogenic stem cell transplantation
- Fresh frozen plasma
- Autologous blood transfusion
- Golimumab
- Autologous stem cell transplantation
- Hydroxychloroquine
- Azathioprine
- IFN-α infusion
- Daunorubicin infusion
- Imatinib
- Donor granulocyte infusion
- Methotrexate
- Donor lymphocyte infusion
- None of the above
A 57 year old woman is known to have chronic myeloid leukaemia. She presents acutely unwell, with 25% myeloblasts on her blood film, and is appropriately treated. 24 months later she relapses.
Donor lymphocyte infusion
Choose the most appropriate treatment option from the list.
- Allogenic blood transfusion
- Dosatinib
- Allogenic stem cell transplantation
- Fresh frozen plasma
- Autologous blood transfusion
- Golimumab
- Autologous stem cell transplantation
- Hydroxychloroquine
- Azathioprine
- IFN-α infusion
- Daunorubicin infusion
- Imatinib
- Donor granulocyte infusion
- Methotrexate
- Donor lymphocyte infusion
- None of the above
A 60 year old woman presents with weight loss and lethargy. On examination, she is cachectic with splenomegaly. Her white cell count is 150 x 109/l. Her blood film showed 25% myeloblasts. Cytogenetic analysis showed presence of the Philadelphia chromosome.
Allogenic stem cell transplantation
Choose the most appropriate treatment option from the list.
- Allogenic blood transfusion
- Dosatinib
- Allogenic stem cell transplantation
- Fresh frozen plasma
- Autologous blood transfusion
- Golimumab
- Autologous stem cell transplantation
- Hydroxychloroquine
- Azathioprine
- IFN-α infusion
- Daunorubicin infusion
- Imatinib
- Donor granulocyte infusion
- Methotrexate
- Donor lymphocyte infusion
- None of the above
A 55 year old man presents with weight loss and lethargy. On examination, he is cachectic with splenomegaly. His white cell count was 135 x 109/l. Cytogenetic analysis showed presence of the Philadelphia chromosome.
Imatinib
Choose the most appropriate treatment option from the list.
- Allogenic blood transfusion
- Dosatinib
- Allogenic stem cell transplantation
- Fresh frozen plasma
- Autologous blood transfusion
- Golimumab
- Autologous stem cell transplantation
- Hydroxychloroquine
- Azathioprine
- IFN-α infusion
- Daunorubicin infusion
- Imatinib
- Donor granulocyte infusion
- Methotrexate
- Donor lymphocyte infusion
- None of the above
A 57 year old man with a history of chronic myeloid leukaemia presents with night sweats, fatigue and weight loss. He was started on first line therapy 6 months ago but his doctor is concerned that he has relapsed. He wants to try a new treatment option.
Dosatinib
Choose the most appropriate treatment option from the list.
- IFN-α
- Dosatinib
- Hydroxycarbamide
- Chemotherapy + all-trans-retinoic acid
- Allogeneic stem cell transplantation
- Chemotherapy (R-CHOP regimen)
- Imatinib
- Chemotherapy (ABVD regimen)
- Chlorambucil
- Chemotherapy (R-CVP regimen)
- Cyclosphosphamide
- Donor lymphocyte infusion
- Monitor clinically and give annual influenza vaccine
- Radiotherapy and 6-8 cycles of chemotherapy
A 50 year old man presented with fatigue, lethargy and weight loss. On examination, he was pale and had gross splenomegaly. His blood film showed an increase in white blood cells (both myelocytes and mature granulocytes). Cytogenetic analysis showed a t(9;22) chromosomal translocation.
Imatinib
Choose the most appropriate treatment option from the list.
- IFN-α
- Dosatinib
- Hydroxycarbamide
- Chemotherapy + all-trans-retinoic acid
- Allogeneic stem cell transplantation
- Chemotherapy (R-CHOP regimen)
- Imatinib
- Chemotherapy (ABVD regimen)
- Chlorambucil
- Chemotherapy (R-CVP regimen)
- Cyclosphosphamide
- Donor lymphocyte infusion
- Monitor clinically and give annual influenza vaccine
- Radiotherapy and 6-8 cycles of chemotherapy
A 74 year old patient has been diagnosed with chronic myeloid leukaemia and 6 months after starting therapy with the first line drug has shown no improvement in FBC or cytogenetics. His physician switches him to another drug.
Dosatinib
Choose the most appropriate treatment option from the list.
- IFN-α
- Dosatinib
- Hydroxycarbamide
- Chemotherapy + all-trans-retinoic acid
- Allogeneic stem cell transplantation
- Chemotherapy (R-CHOP regimen)
- Imatinib
- Chemotherapy (ABVD regimen)
- Chlorambucil
- Chemotherapy (R-CVP regimen)
- Cyclosphosphamide
- Donor lymphocyte infusion
- Monitor clinically and give annual influenza vaccine
- Radiotherapy and 6-8 cycles of chemotherapy
A 48 year old patient with chronic myeloid leukaemia becomes acutely unwell. A peripheral blood film shows 30% myeloblasts.
Allogeneic stem cell transplantation
Choose the most appropriate treatment option from the list.
- IFN-α
- Dosatinib
- Hydroxycarbamide
- Chemotherapy + all-trans-retinoic acid
- Allogeneic stem cell transplantation
- Chemotherapy (R-CHOP regimen)
- Imatinib
- Chemotherapy (ABVD regimen)
- Chlorambucil
- Chemotherapy (R-CVP regimen)
- Cyclosphosphamide
- Donor lymphocyte infusion
- Monitor clinically and give annual influenza vaccine
- Radiotherapy and 6-8 cycles of chemotherapy
A 59 year old patient with chronic myeloid leukaemia has been found to be positive for the Philadelphia chromosome several years following his stem cell transplantation.
Donor lymphocyte infusion
Choose the most appropriate treatment option from the list.
- IFN-α
- Dosatinib
- Hydroxycarbamide
- Chemotherapy + all-trans-retinoic acid
- Allogeneic stem cell transplantation
- Chemotherapy (R-CHOP regimen)
- Imatinib
- Chemotherapy (ABVD regimen)
- Chlorambucil
- Chemotherapy (R-CVP regimen)
- Cyclosphosphamide
- Donor lymphocyte infusion
- Monitor clinically and give annual influenza vaccine
- Radiotherapy and 6-8 cycles of chemotherapy
A 61 year old patient with chronic myeloid leukaemia has not responded to different tyrosine kinase inhibitors available.
Allogeneic stem cell transplantation